Inhalational Gentamicin Treatment Is Effective Against Pneumonic Plague in a Mouse Model

Dynamics of the pneumonic plague epidemic in Madagascar, August to October 2017

(2017) Shinya Tsuzuki et al.   Eurosurveillance

Host transcriptomic responses to pneumonic plague reveal that Yersinia pestis inhibits both the initial adaptive and innate immune responses in mice

(2017) Huiying Yang et al.   INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY

Host Iron Nutritional Immunity Induced by a Live Yersinia pestis Vaccine Strain Is Associated with Immediate Protection against Plague

(2017) Ayelet Zauberman et al.   Frontiers in Cellular and Infection Microbiology

Inhaled Liposomal Ciprofloxacin Protects against a Lethal Infection in a Murine Model of Pneumonic Plague

(2017) Karleigh A. Hamblin et al.   Frontiers in Microbiology

Development of Liposomal Ciprofloxacin to Treat Lung Infections

(2016) David Cipolla et al.   Pharmaceutics

Circumventing Y. pestis Virulence by Early Recruitment of Neutrophils to the Lungs during Pneumonic Plague

(2015) Yaron Vagima et al.   PLoS Pathogens

Pharmacokinetics and Pharmacodynamics of Aerosolized Antibacterial Agents in Chronically Infected Cystic Fibrosis Patients

(2014) Axel Dalhoff   CLINICAL MICROBIOLOGY REVIEWS

Inhaled versus nebulised tobramycin: A real world comparison in adult cystic fibrosis (CF)

(2014) M.J. Harrison et al.   Journal of Cystic Fibrosis

Hypoxic Pulmonary Vasoconstriction

(2012) J. T. Sylvester et al.   PHYSIOLOGICAL REVIEWS

Early sensing of Yersinia pestis airway infection by bone marrow cells

(2012) Yaron Vagima et al.   Frontiers in Cellular and Infection Microbiology

Penetration of Anti-Infective Agents into Pulmonary Epithelial Lining Fluid

(2011) Keith A. Rodvold et al.   CLINICAL PHARMACOKINETICS

Aerosolized antibiotics for treating hospital-acquired and ventilator-associated pneumonia

(2011) G Christopher Wood   Expert Review of Anti-Infective Therapy

Safety, efficacy and convenience of tobramycin inhalation powder in cystic fibrosis patients: The EAGER trial

(2010) Michael W. Konstan et al.   Journal of Cystic Fibrosis